Skip to main content
    E

    Encompass Health Corp (EHC)

    Official site

    HEALTHCARE • MEDICAL CARE FACILITIES • NYSE

    $142.17
    +1.18 (+0.84%)

    Market Cap: $13.83B

    Last updated: Nov 17, 2026 at 11:05 AM ET

    Encompass Health Corp (EHC) P/E Ratio & Valuation History

    Updated Nov 17, 2026. Multiples are computed from end-of-day prices, company filings and consensus analyst estimates.

    Encompass Health (EHC) trades at 23.2x trailing earnings and 2.2x sales. Its P/E of 23.2x is above its 5-year median of 19.5x. Its forward P/E is 19.1x. The median P/E across 12 similar companies is 17.8x.

    Current Multiples

    Its forward P/E is below its trailing P/E, which implies earnings per share about 21.5% higher over the next year. Its free cash flow yield is 3.3%.

    MultipleValue
    P/E (trailing)23.2x
    Forward P/E19.1x
    Price to sales2.2x
    EV/EBITDA10.6x
    Price to FCF30.6x
    EV/FCF36.1x
    PEG0.4
    FCF yield3.3%
    As of Nov 17, 2026

    Historical Medians

    Against its 10-year medians, its P/E is 19.0% above 19.5x and its P/S is 37.5% above 1.6x.

    MultipleCurrent5-year median10-year median
    P/E23.2x19.5x19.5x
    P/S2.2x1.7x1.6x
    Medians of month-end values through Oct 2026: 60 months (5-year) and 107 months (10-year).

    Valuation History

    Over the 9 year ends shown, its P/E ranged from 15.5x in 2021 to 28.6x in 2020.

    Year endPriceP/EP/SP/B
    2025$106.1419.4x1.8x4.4x
    2024$92.3520.8x1.7x4.6x
    2023$66.7218.3x1.4x4.1x
    2022$59.8117.5x1.4x4.6x
    2021$65.2615.5x1.6x3.4x
    2020$82.6928.6x2.3x5.2x
    2019$69.2717.8x1.5x5.1x
    2018$61.7017.0x1.4x4.6x
    2017$49.4117.8x1.2x4.1x
    Each year's multiples use the split-adjusted closing price of that year's last trading day over trailing per-share results as reported; periods with losses are left out.

    GNG Valuation

    GNG viewFairly valued

    GNG fair value is part of GNG Pro. See plans

    Frequently Asked Questions About EHC

    What is EHC's forward P/E ratio?

    Encompass Health has a forward P/E ratio of 19.1x.

    Is EHC stock overvalued?

    GNG's valuation label for EHC is Fairly valued. Its P/E of 23.2x compares with a median of 17.8x across 12 similar companies.

    What is EHC's price to sales ratio?

    Encompass Health has a price to sales ratio of 2.2x.

    What is Encompass Health's average P/E ratio over 5 years?

    Encompass Health's median P/E over the last 5 years is 19.5x, from 60 month-end values through Oct 2026.

    What is EHC's PEG ratio?

    Encompass Health has a PEG ratio of 0.4.